PET/Computed Tomography Scanning and Precision Medicine: Esophageal Cancer

Reema Goel, Rathan M Subramaniam, Jason W. Wachsmann

Research output: Contribution to journalReview articlepeer-review

Abstract

Esophageal cancer commonly has a poor prognosis, which requires an accurate diagnosis and early treatment to improve outcome. Other modalities for staging, such as endoscopic ultrasound imaging and computed tomography (CT) scans, have a role in diagnosis and staging. However, PET with fluorine-18 fluoro-2-deoxy-D-glucose/CT (FDG PET/CT) scanning allows for improved detection of distant metastatic disease and can help to prevent unnecessary interventions that would increase morbidity. FDG PET/CT scanning is valuable in the neoadjuvant chemotherapy assessment and predicting survival outcomes subsequent to surgery. FDG PET/CT scanning detects recurrent disease and metastases in follow-up.

Original languageEnglish (US)
Pages (from-to)373-391
Number of pages19
JournalPET Clinics
Volume12
Issue number4
DOIs
StatePublished - Oct 2017
Externally publishedYes

Keywords

  • Esophageal cancer
  • Esophageal carcinoma
  • FDG PET/CT
  • PET
  • PET/CT

ASJC Scopus subject areas

  • Radiation
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'PET/Computed Tomography Scanning and Precision Medicine: Esophageal Cancer'. Together they form a unique fingerprint.

Cite this